MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 55, Issue 3, 2017, Pages 1223-1233

  Lusardi, Theresa A ^a   Phillips, Jay I ^b   Wiedrick, Jack T ^a   Harrington, Christina A ^a   Lind, Babett ^b   Lapidus, Jodi A ^a   Quinn, Joseph F ^b,c   Saugstad, Julie A ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; ApoE; biomarker; cerebrospinal fluid; microRNA; PCR

Indexed keywords

APOLIPOPROTEIN E; MICRORNA; MICRORNA 125B 5P; MICRORNA 1291; MICRORNA 140 5P; MICRORNA 142 3P; MICRORNA 143 3P; MICRORNA 145 3P; MICRORNA 146A 5P; MICRORNA 15B 5P; MICRORNA 16 5P; MICRORNA 193A 5P; MICRORNA 195 5P; MICRORNA 19B 3P; MICRORNA 202 3P; MICRORNA 223 3P; MICRORNA 24 3P; MICRORNA 26B 5P; MICRORNA 29A 3P; MICRORNA 30A 3P; MICRORNA 30D 5P; MICRORNA 328 3P; MICRORNA 340 5P; MICRORNA 378A 3P; MICRORNA 484; MICRORNA 519B 3P; MICRORNA 520B; MICRORNA 584 5P; MICRORNA 597 5P; MICRORNA 603; UNCLASSIFIED DRUG; AMYLOID; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; MESSENGER RNA;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RANDOM FOREST; SENSITIVITY AND SPECIFICITY; DIAGNOSTIC IMAGING; GENETICS; MENTAL HEALTH; METABOLISM; POSITRON EMISSION TOMOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; APOLIPOPROTEIN E4; BIOMARKERS; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MENTAL STATUS SCHEDULE; MICRORNAS; POSITRON-EMISSION TOMOGRAPHY; RNA, MESSENGER; ROC CURVE;

EID: 85005939314     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160835     Document Type: Article

References (35)

1. Ghidoni R, Benussi L, Paterlini A, Albertini V, Binetti G, Emanuele E. (2011) Cerebrospinal fluid biomarkers for Alzheimer?s disease: The present and the future. Neurodegener Dis 8, 413-420.
2. Quinn JF. (2013) Biomarkers for Alzheimer?s disease: Showing the way or leading us astray?. J Alzheimers Dis 33(Suppl 1), S371-S376.
3. Rao P, Benito E, Fischer A. (2013) MicroRNAs as biomarkers for CNS disease. Front Mol Neurosci 6, 39.
4. Quinn JF, Patel T, Wong D, Das S, Freedman JE, Laurent LC, Carter BS, Hochberg F, VanKeuren-Jensen K, Huentelman M, Spetzler R, Kalani MY, Arango J, Adelson PD, Weiner HL, Gandhi R, Goilav B, Putterman C, Saugstad JA. (2015) Extracellular RNAs: Development as biomarkers of human disease. J Extracell Vesicles 4, 27495.
5. Chekulaeva M, Filipowicz W. (2009) Mechanisms of miRNA-mediated post-Transcriptional regulation in animal cells. Curr Opin Cell Biol 21, 452-460.
6. Bartel DP. (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233.
7. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP. (2008) The impact of microRNAs on protein output. Nature 455, 64-71.
8. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA. (2008) Identification of miRNAchanges in Alzheimer?s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14, 27-41.
9. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B. (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer?s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 105, 6415-6420.
10. Geekiyanage H, Chan C. (2011) MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer?s disease. J Neurosci 31, 14820-14830.
11. Geekiyanage H, Jicha GA, Nelson PT, Chan C. (2012) Blood serum miRNA: Non-invasive biomarkers for Alzheimer?s disease. Exp Neurol 235, 491-496.
12. Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K, Oda Y. (2013) Circulating miRNA biomarkers for Alzheimer?s disease. PLoS One 8, e69807.
13. Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C, Sabbagh M, Villa S, Tembe W, Craig D, Van Keuren-Jensen K. (2014) Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer?s and Parkinson?s diseases correlate with disease status and features of pathology. PLoS One 9, e94839.
14. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T. (2014) MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer?s disease. J Alzheimers Dis 39, 253-259.
15. Dorval V, Nelson PT, Hebert SS. (2013) Circulating microRNAs in Alzheimer?s disease: The search for novel biomarkers. Front Mol Neurosci 6, 24.
16. Kim DH, Yeo SH, Park JM, Choi JY, Lee TH, Park SY, Ock MS, Eo J, Kim HS, Cha HJ. (2014) Genetic markers for diagnosis and pathogenesis of Alzheimer?s disease. Gene 545, 185-193.
17. Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J. (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69, 570-580.
18. Subramanian SL, Kitchen RR, Alexander R, Carter BS, Cheung KH, Laurent LC, Pico A, Roberts LR, Roth ME, Rozowsky JS, Su AI, Gerstein MB, Milosavljevic A. (2015) Integration of extracellular RNA profiling data using metadata, biomedical ontologies and Linked Data technologies. J Extracell Vesicles 4, 27497.
19. Breiman L. (2001) Random Forests. Machine Learning 45, 5-32.
20. Hothorn T, Hornik K, Zeileis A. (2006) Unbiased recursive partioning: A conditional inference network. J Comput Graph Stat 15, 651-674.
21. Kass GV. (1980) An exploratory technique for investigating large quantities of categorical data. J R Stat Soc Ser C Appl Stat 29, 119-127.
22. Pepe MS (2003) the Statistical Evaluation of Medical Tests for Classification and Prediction, Oxford University Press, Oxford, New York, Pp. 220-224.
23. Hastie T, Tibshirani R, Friedman J. (2009) The Elements of Statistical Learning: Data Mining, Inference, and Prediction, Springer, New York.
24. Little R, Rubin D. (2002) Statistical Analysis with Missing Data, Wiley-Interscience, New Jersey.
25. Folstein MF, Robins LN, Helzer JE. (1983) The Mini-Mental State Examination. Arch Gen Psychiatry 40, 812.
26. Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, Lee VM, Galasko DR. (2006) Age and apolipoprotein E4 allele effects on cerebrospinal fluid beta-Amyloid 42 in adults with normal cognition. Arch Neurol 63, 936-939.
27. Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR. (2013) Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults. Neurology 81, 2024-2027.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. (1984) Clinical diagnosis of Alzheimer?s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer?s Disease. Neurology 34, 939-944.
29. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. (2011) The diagnosis of dementia due to Alzheimer?s disease: Recommendations from the National Institute on Aging-Alzheimer?s Association workgroups on diagnostic guidelines for Alzheimer?s disease. Alzheimers Dement 7, 263-269.
30. Seshadri S, Drachman DA, Lippa CF. (1995) Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer?s disease. What physicians know, and what they should know. Arch Neurol 52, 1074-1079.
31. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, Bertone P, Caldas C. (2010) Systematic comparison of microarray profiling, real-Time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16, 991-1006.
32. Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, Arighi A, Fumagalli G, Scarpini E. (2014) Circulating miRNAs as potential biomarkers in Alzheimer?s disease. J Alzheimers Dis 42, 1261-1267.
33. Muller M, Kuiperij HB, Claassen JA, Kusters B, Verbeek MM. (2014) MicroRNAs in Alzheimer?s disease: Differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35, 152-158.
34. Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H. (2015) MicroRNAprofiling of CSF reveals potential biomarkers to detect Alzheimer?s disease. PLoS One 10, e0126423.
35. Muller M, Kuiperij HB, Versleijen AA, Chiasserini D, Farotti L, Baschieri F, Parnetti L, Struyfs H, De Roeck N, Luyckx J, Engelborghs S, Claassen JA, Verbeek MM. (2016) Validation of microRNAs in cerebrospinal fluid as biomarkers for different forms of dementia in a multicenter study. J Alzheimers Dis 52, 1321-1333.